MedPath

LABORATOIRES TERIAK

🇹🇳Tunisia
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:1

Trial Phases

1 Phases

Phase 4:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 4
1 (100.0%)

Incidence of Major Cardiovascular Events in Diabetic Patients With ACS Undergoing Coronary Angioplasty and Treated With Clopidogrel 150 mg Versus 75 mg

Phase 4
Completed
Conditions
Diabetes Mellitus, Type 2
NSTEMI - Non-ST Segment Elevation MI
Coronary Angioplasty
Interventions
First Posted Date
2017-11-01
Last Posted Date
2019-12-23
Lead Sponsor
Laboratoires Teriak
Target Recruit Count
167
Registration Number
NCT03329261
Locations
🇹🇳

HMPIT, Ben Arous, Tunisia

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.